In new research published in Nature, researchers from the University of Chicago show how mice fed a Western-style diet are not able to rebuild a “healthy,” diverse gut microbiome following antibiotic treatment. These mice were also more susceptible to infection by pathogens like Salmonella. However, mice given food loosely mimicking a Mediterranean diet—high in plant-based fiber from fruits, vegetables, and whole grains—were able to quickly restore a healthy and resilient gut microbiome after antibiotics.

Half of U.S. adults say they know eating a plant-based diet can improve their health and help prevent chronic diseases, according to a new Physicians Committee for Responsible Medicine/Morning Consult survey. However, the survey also showed that just 1 in 5 primary care practitioners discuss this lifesaving message with patients.

An online physician-led plant-based nutrition intervention program for patients with type 2 diabetes is practical, cost-effective, and successful at improving patient health, finds a new study by the Physicians Committee for Responsible Medicine published in the American Journal of Lifestyle Medicine.

About The Study: In this cohort study of sexual and gender minority (SGM) young adults assigned male at birth, exposure to sexual orientation and gender identity change efforts (SOGICE) was associated with adverse cardiovascular health indicators, including elevated diastolic blood pressure and systolic blood pressure, increased systemic inflammation, and higher odds of self-reported hypertension or high blood pressure. These findings underscore the need for public health and policy interventions to enforce and strengthen bans on SOGICE practices. Recognizing the cardiovascular health consequences of SOGICE contributes to addressing SGM health disparities and emphasizes the importance of affirmative care approaches that prioritize the well-being of SGM individuals.

The European College of Neuropsychopharmacology (ECNP) is pleased to announce Professor Carmen Sandi as the recipient of the 2025 ECNP Neuropsychopharmacology Award (preclinical), in recognition of her achievements in advancing the understanding of the neurobiological mechanisms of stress and anxiety and their impacts on brain and behaviour. The ECNP Neuropsychopharmacology Award is presented annually and recognises distinguished research in applied and translational neuroscience.